| Literature DB >> 24566728 |
Vaishali Bane1, Mary Lehane2, Madhurima Dikshit3, Alan O'Riordan4, Ambrose Furey5.
Abstract
Tetrodotoxin (TTX) is a naturally occurring toxin that has been responsible for human intoxications and fatalities. Its usual route of toxicity is via the ingestion of contaminated puffer fish which are a culinary delicacy, especially in Japan. TTX was believed to be confined to regions of South East Asia, but recent studies have demonstrated that the toxin has spread to regions in the Pacific and the Mediterranean. There is no known antidote to TTX which is a powerful sodium channel inhibitor. This review aims to collect pertinent information available to date on TTX and its analogues with a special emphasis on the structure, aetiology, distribution, effects and the analytical methods employed for its detection.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24566728 PMCID: PMC3942760 DOI: 10.3390/toxins6020693
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Worldwide occurrence of tetrodotoxin (TTX) poisoning.
| Country | Causative Organism | Analogues of TTX found | No. of cases | Year of poisoning incident | Reference |
|---|---|---|---|---|---|
| Australia | Toadfish | TTX | 7 | 2004 | [ |
| Australia | Puffer fish | TTX | 11 | 1 January 2001 to 13 April 2002 | [ |
| Bangladesh | Puffer fish, Dora potka | TTX | 141 (Three outbreaks) | 9 April 2008 (Narsingdi District) | [ |
| Bangladesh | Puffer fish | TTX | 53 | May 2001–May 2006 | [ |
| Bangladesh (Khulna district) | Puffer fish | TTX | 37 (8 died) | April 2002 | [ |
| Bangladesh (Degholia in the Khulna district) | Puffer fish, | TTX | 36 (7 died) | May 2002 | [ |
| Bangladesh | Puffer fish, | TTX | 8 (5 died) | 1998 | [ |
| China (Lianyungang) | Gastropod, | TTX, trideoxyTTX, 4-epiTTX, anhydroTTX and oxoTTX | - | May–August 2007 | [ |
| China (South Zheijiang, Mainland) | Gastropod, | TTX | 30 | June 2001 | [ |
| India (Orissa state, Burla) | Puffer fish | TTX | 8 | October 2007 | [ |
| Japan | – | TTX | Numerous | 1965–2010 | [ |
| Japan | Puffer fish “kinfugu”, | TTX | 1 | October 2008 | [ |
| Japan | Thread-sail filefish “Kawahagi” | TTX | 1 | October 2008 | [ |
| Japan | Marine snail, | TTX | 1 | July 2007 | [ |
| Japan | Marine snail, | TTX | 2 | December 1987 | [ |
| Japan | Marine snail, | TTX | 1 | December 1979 | [ |
| Japan | Marine snail (Ivory shell), | TTX | 5 | June 1957 | [ |
| Korea | Unknown fish | TTX | 3 | October 2010 | [ |
| Mediterranean region (Egypt and Israel) | Puffer fish, | TTX | 13 | November 2005, February 2007, March 2007, November 2007, March 2008 and May 2008 | [ |
| New Zealand | Grey side-gilled sea slug, | TTX | 15 dogs | July to November 2009 | [ |
| Spain (Malaga; caught from Portuguese waters) | Trumpet shell, | TTX | – | October 2007 | [ |
| Taiwan (Kaohsiung) | Gastropod, | TTX | 3 | November 2006 | [ |
| Taiwan | Gastropod | TTX and PSP | 1 | October 2005 | [ |
| Taiwan (Southern China Sea) | Marine snail, | TTX | 5 | April 2004 | [ |
| Taiwan (Tungsa Island) | Gastropod, | TTX | 6 | April 2004 | [ |
| Taiwan (Western) | Gastropod, | TTX | – | 2003 | [ |
| Taiwan (Tungkang, Southern Taiwan) | Gastropods, | TTX | 1 | February 2002 | [ |
| Taiwan | Unknown fish | TTX | 6 (1 died) | April 2001 | [ |
| Taiwan | Puffer fish, | TTX | 6 (1 died) | April 2001 | [ |
| Taiwan (Northern) | Gastropods (snails), | TTX | 4 | April 2001 | [ |
| Taiwan (Chunghua Prefecture, Western Taiwan) | Puffer fish, | TTX | 5 | Jan 2000 | [ |
| Thailand (Chon Buri, Eastern Thailand) | Eggs of horseshoe crab, | TTX | 71 | 1995 | [ |
| US (New Hampshire, New York, Pennsylvania and Virginia) | Newt, | TTX, 6-epiTTX and 11-oxoTTX | Collected samples for analysis | 2001–2009 | [ |
| US (Chicago) | Puffer fish | TTX | 2 | May 2007 | [ |
| US (California) | Puffer fish transported from Japan | TTX | 3 | April 1996 | [ |
| US (Hawaii) | Puffer fish, | TTX | 1 | 1986 | [ |
Figure 1Structures of TTX analogues.
Commercial sources for TTX.
| No. | Name of TTX analogue | Source for extraction | Purity (%) | CAS No. | Contact details |
|---|---|---|---|---|---|
| 1 | Tetrodotoxin (citrate free) | 96 (HPLC‚ IR‚ NMR) | 4368-28-9 | [ | |
| 2 | Tetrodotoxin (citrate free) | 100 | 4368-28-9 | [ | |
| 3 | Tetrodotoxin (citrate free) | NM | NM | 4368-28-9 | [ |
| 4 | Tetrodotoxin (citrate free) | NM | NM | 4368-28-9 | [ |
| 5 | Tetrodotoxin (MW 328.28) | NM | 4368-28-9 | [ | |
| 6 | Tetrodotoxin (MW 319.27) C11H17N3O8 | NM | ≥98 (HPLC) | 4368-28-9 | [ |
| 7 | Tetrodotoxin (citrate free), C11H17N3O8, MW 319.3 | NM | NM | 4368-28-9 | [ |
| 8 | Tetrodotoxin (citrate free), C11H17N3O8, MW 319.28 |
| >98 | 4368-28-9 | [ |
| 9 | Tetrodotoxin (citrate free), C11H17N3O8, MW 319.3 | ≥95 by TLC | 4368-28-9 | [ | |
| 10 | Tetrodotoxin (citrate free), C11H17N3O8, MW 319.2 | NM | >98 | 4368-28-9 | [ |
| 11 | Tetrodotoxin citrate, C11H17N3O8, MW 319.27 |
| >98 | 18660-81-6 | [ |
| 12 | Tetrodotoxin citrate, C11H17N3O8, MW 319.27 | NM | >98 | 4368-28-9 | [ |
| 13 | Tetrodotoxin (citrate free), C11H17N3O8, MW 319.27 | NM | NM | 4368-28-9 | [ |
| 14 | Tetrodotoxin (citrate free), C11H17N3O8, MW 319.3 | NM | NM | 4368-28-9 | [ |
Note: NM, Not mentioned.
Sources of TTX analogues.
| No. | Analogue | Exact Molar Mass | Molecular Formula | MRM | Source Organism |
|---|---|---|---|---|---|
| 1 | 4-S-Cys TTX | 422.110753 | C14H22N4O9S | NR | Puffer fish: |
| 2 | TTX-8-O-hemisuccinate | 418.109787 | C15H20N3O11 | NR | Synthetic analogue [ |
| 3 | Chiriquitoxin | 392.117945 | C13H20N4O10 | NR | Toad |
| 4 | 11-oxoTTX | 335.096482 | C11H17N3O9 | 336/318 | Puffer fish: Gastropod: Xanthid crab: Newt: Frog: |
| 5 | TTX-11-carboxylic acid | 332.073007 | C11H14N3O9− | NR | Synthetic analogue [ |
| 6 | TTX | 319.101567 | C11H17N3O8 | 320/302 | Puffer fish: Gastropod: Crab: Newt: Frog: Blue-ringed octopus: Starfish: Sea slug: Copepod: Ribbon worm: Bacteria: |
| 7 | 4-epiTTX | 319.101567 | C11H17N3O8 | 320/302 | Puffer Fish: Gastropod: Crab: Newt: Frog: Blue-ringed octopus: Copepods: Ribbon worm: Bacteria: |
| 8 | 6-epiTTX | 319.101567 | C11H17N3O8 | 320/302 |
Puffer Fish: Newt: Frog: |
| 9 | Tetrodonic acid | 319.101567 | C11H17N3O8 | NR | Puffer Fish [ Newt: Frog: |
| 10 | 11-norTTX-6,6-diol | 305.085917 | C10H15N3O8 | NR | Synthetic analogue [ |
| 11 | 5-deoxyTTX | 303.106652 | C11H17N3O7 | 304/286 |
Puffer Fish: Newt: Frog: |
| 12 | 11-deoxyTTX | 303.106652 | C11H17N3O7 | 304/286 |
Puffer Fish: Newt: Frog: |
| 13 | 1-hydroxy-5,11-dideoxyTTX | 303.106652 | C11H17N3O7 | NR | Newt: |
| 14 | 4,9-anhydro TTX | 301.091002 | C11H15N3O7 | 302/256 |
Puffer Fish: Gastropod: Xanthid crab: Newt: Frog: |
| 15 | 6-epi-4,9-anhydroTTX | 301.091002 | C11H15N3O7 | 302/256 | Newt: |
| 16 | AnhydroTTX | 300.083177 | C11H14N3O7− | 302/256 | Puffer Fish: Gastropod: Crab: Newt: Frog: Blue-ringed octopus: Copepods: Ribbon worm: Bacteria: |
| 17 | 11-norTTX-6(S)-ol | 289.091002 | C10H15N3O7 | 290/272 |
Puffer Fish: Frog: Newt: Sea slug: |
| 18 | 11-norTTX-6(R)-ol | 289.091002 | C10H15N3O7 | 290/272 |
Puffer Fish: Crab: Newt: Sea slug: |
| 19 | 1-hydroxy-8-epi-5,6,11-trideoxy TTX | 287.111737 | C11H17N3O6 | 288/162 |
Puffer Fish: Newt: |
| 20 | 6,11dideoxyTTX | 287.111737 | C11H17N3O6 | 288/224 |
Puffer Fish: Newt: |
| 21 | 8,11dideoxyTTX | 287.111737 | C11H17N3O6 | NR | Synthetic analogue [ |
| 22 | 5,6,11-trideoxy TTX | 271.116822 | C11H17N3O5 | 272/254 | Puffer Fish: Gastropod: |
| 23 | 8-epi-5,6,11-trideoxy TTX | 271.116822 | C11H17N3O5 | 272/162 | Newt: |
| 24 | 4-epi-5,6,11-trideoxyTTX | 271.116822 | C11H17N3O5 | NR | Puffer fish [ |
| 25 | 1-hydroxy-4,4a-anhydro-8-epi-5,6,11-trideoxyTTX | 269.101172 | C11H15N3O5 | 270/162 | Puffer Fish: Newt: |
| 26 | 4,9-anhydro-5,6,11-trideoxy TTX | 253.106257 | C11H15N3O4 | NR | Puffer fish [ |
| 27 | 4,9-anhydro-8-epi-5,6,11-trideoxy TTX | 253.106257 | C11H15N3O4 | 254/162 | Newt: |
| 28 | 4,4a-anhydro-5,6,11-trideoxy TTX | 253.106257 | C11H15N3O4 | NR | Puffer fish [ |
| 29 | 4-epi-11-deoxyTTX | NR | NR | NR | Newt ( |
| 30 | 4,9-anhydro-11-deoxyTTX | NR | NR | NR | Newt ( |
Note: NR, Not Reported.
Figure 2Chemical synthesis of TTX from glucose [119] (R = MOM).
Figure 3Proposed biosynthesis of tetrodotoxin from arginine [49,111].
Figure 4Proposed mechanism of TTX accumulation in marine animals [14].
Figure 5Structures of paralytic shellfish poisons (PSP) toxins.
LC-MS methods for TTX and its analogues from puffer fish.
| Species | Extraction | Column | Mobile phase | Method | Analyte * | LOD and LOQ | Linear Range | Reference |
|---|---|---|---|---|---|---|---|---|
| 0.1% AA | Zorbax 300SB-C3 | Isocratic: 1% ACN + 10mM TMA + 10 mM AF, pH 4 (For Zorbax 300SB-C3) | LC-MS/MS and CID-MS/MS | 6, 7, 11, 12, 14, 17, 18, 22 | LOD:16 ng/mL at S/N > 3 | 62.5–2000 ng/mL | [ | |
| ASE and SE (0.03 M AA) | Acquity UPLC BEH HILIC | A: 5% ACN | LC-M/MS | 6 | For Solvent Std LOD: 0.074 ng/mL | 5–500 ng/mL (Solvent Std) | [ | |
| Potka or Tepa fish (Cooked fishAnd blood and urine of victim) | 1% AA + 80% MeOH | C30 UG-5 | A: 30 mM AHB, pH 5 in H2O | LC-FLD | 6, 7, 14 | NR | NR | [ |
| 0.1% AA, ethyl acetate Defat *, CharAd † | ZIC-HILIC | A: 10 mM AF + 10 mM FA in H2O | LC-MS/MS | 6, 11/12, 16 | NR | NR | [ | |
| Puffer fish (ovary) | 0.05 M AA, ODS-SPE, Ultra filtration (0.22 µ) | Atlantis HILIC Silia | 10 mM AF, pH 3.5 + ACN (22:78, v/v) | LC-MS (SIR) | 6, 7, 9, 11, 14, 17/ 18, 20, 22 | SIR mode | 0.25–100 ng/mL | [ |
| 1% AA | Puresil C18 | 30 mM HFB + 1 mM Am-acetate, pH 5.0 | LC-MS | 6, 7, 14 | NR | NR | [ | |
| 0.05 M AA, C18-SPE, CHCl3 Defat *, CharAd † | TSKgel Amide-80 | 16 mM AF, pH 5.5 in ACN (3:7, v/v) | LC-MS/MS | 6, 7, 11, 12, 14, 20, 22 | NR | NR | [ | |
| 1% AA, CHCl3 Defat * | TSK-GEL Amide-80 | 5 mM AF + 26.5 mM FA in ACN:H2O, 70:30 | LC-MS | 6 | NR | NR | [ | |
| NM | RP-18 | 1 mM TBA-PO4, pH 5.8 | HPLC-FLD | PSP toxins (STX, neoSTX, GTX1–4, dcSTX, dcGTX2 and 3) | NR | NR | [ | |
| Sephadex G-10 Gel filtration (For | For | 5 mM AHB + 50 mM Am-acetate, pH 5 in 3% ACN; LC-FLD (For | LC-FLD | 1, 4, 6, 7, 14 (on ODS-5) and 11, 12, 20, 22 (on HILIC) | NR | NR | [ | |
| 0.1% AA | ODS-5 | 20 mM AHB, pH 5 + 10 mM Am-acetate, pH 5 in 3% MeCN | LC-FLD | 6, 7, 14 | NR | NR | [ | |
| 0.1% AA | SeQuant ZIC- HILIC | A: 10 mM AF + 10 mM FA in water | LC-MS/MS | 6, 7, 12, 16, 22 | LOD:0.09 ng (TTX), 0.14 ng(AnhydroTTX), 0.20 ng (11-deoxy TTX) | 0.25–10 ng (TTX) | [ | |
| 0.05 M AA, EtOAc Defat *, CharAd †, Bio-Gel P2 and Hitachi gel 3011C filtration | TSK gel Amide-80 | 16 mM AF, pH 5.5 in ACN (3:7, v/v) | LC-MS | 6, 7, 11, 12, 14, 17, 20, 22 | NR | NR | [ | |
| 0.1% AA, Cosmosil 75 C18-OPN resin | C30 UG-5 (LC-FLD) TSK-GEL Amide-80 (LC/MS) | 30 mM AHB + 10 mM AF in 1% ACN, pH 5 (C30 UG-5) | LC-FLD | 1, 6, 11, 12, 14, 22, | LOD 0.07 pmole (LC-MS) | NR | [ | |
| 0.05 M AA, CharAd † | C30 UG-5 (LC-MS/MS and LC-FLD) | 20 mM AHB + 10 mM AF in 1% ACN, pH 4 (LC-MS/MS) | LC-MS/MS | 6, 7, 10, 11, 14, 17, 18, 22 | LOD 0.7 pmol at S/N 2 | 50–1000 pmol | [ | |
| 0.05 M Tris-Ac, pH 8.2; Sephacryl S-400 column filtration, 0.03 M AA, DCM Defat *, Bio-Gel P-2 filtration | YMC AM OSD | [ | LC-FLD | 6, 7, 9, 11 | NR | NR | [ |
Note: (Analyte*) Refer to Table 3 for the name of the TTX analytes.
LC-MS methods for TTX and its analogues from trumpet shell, gastropods and octopus.
| Species | Extraction | Column | Mobile phase | MS | Analyte * | LOD and LOQ | Linear Range | Reference |
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| ASE ‡ and SE ‡‡ (0.03 M AA) | Acquity UPLC BEH HILIC | A: 5% ACN | LC-MS/MS | 6 | For Solvent Std LOD: 0.074 ng/mL | 5–500 ng/mL (Solvent Std) | [ | |
| NM | NM | NM | LC-MS/MS | 6, 22 | NR | NR | [ | |
|
| ||||||||
| [ | [ | [ | HPLC-MSn (Ion trap) and HPLC-FLD | 4, 6, 7, 16, 22 | NR | NR | [ | |
| 1% AA, DCM Defat *, C18 SPE | XBridge™ Amide (LC- MS/MS) | For both, | LC-MS/MS | 6, 7, 11/12, 14, 17/18, 22 | For LC- MS/MS | 50–2000 ng/mL (LC-MS/MS) | [ | |
| Grey side-gilled sea slug, | 50% MeOH, Strata Phenomonex SPE | TSK-GEL amide 80 | A: 10% ACN + (90% 50 mM FA + 2 mM AF in H2O) | LC-MS/MS | 4, 6, 12, 16, 17/18 | LOD: 5 ng/mL (S/N = 50) | 5–250 ng/mL | [ |
|
| ||||||||
| 0.05 N AA | Synergi 4 µ Hydro-RP 80A C18 | 0.97% Heptafluorobutyric acid + 0.29% AA in 3% ACN (pH adjusted to 5.0 with NH4OH) | Q-TOF MS | 6 | NR | 500 ng/mL to 0.5 mg/mL | [ | |
| Blue-ringed octopus ( | 0.05 N AA | Synergi 4 µ Hydro-RP 80A C18 | 3% ACN + 0.97% HFB + 0.29% AA, pH 5 | LC-FLD | 6 | NR | 500 ng/mL–0.5 mg/mL | [ |
Note: (Analyte*) Refer to Table 3 for the name of the TTX analytes.
LC-MS methods for newts.
| Species | Extraction | Column | Mobile phase | MS | Analytes * | LOD and LOQ | Linear Range | Reference |
|---|---|---|---|---|---|---|---|---|
| O.2 M AA, Hexane Defat *, CharAd †, Bio-Rex 70 and Hitachi gel 3011C SPE | TSK gel G1000PW (HILIC) | 16 mM AF, pH 5.5 + ACN (3:7, v/v) | LC-MS/MS | 6, 7, 8, 11, 12, 14, 17, 19, 20, 23, 25, 27 | NR | NR | [ | |
| 0.1% AA + 70% EtOH, CharAd † | Develosil C30 UG-5 | 1% ACN + 20 mM | LC-FLD | 4, 6, 8 | NR | NR | [ | |
| 0.1% AA in 70% MeOH | Develosil C30 UG-5 | 1% ACN + 30 mM AHB + 10 mM AF, pH 5.0 | LC-FLD | 6, 7, 8, 14, 15, | LOD 0.4 pmol | 50–1000 | [ | |
| 0.1% AA in 70% MeOH, CharAd † | Develosil (C30-UG-5) | 30 mM AHB + 10 mM AF, pH 5 | LC-FLD | 6, 8 | LOD | NR | [ | |
| 0.1 M AA | Synergi 4 µ Hydro-RP 80A | 50 mM Am-acetate + 60 mM AHB, pH 5 in 1% ACN | LC-FLD | 6 | NR | NR | [ | |
| 1% AA in 70% MeOH | Develosil C30-UG-5 | 1:11 vol.% ACN, 30 mM AHB + 10 mMAF, pH 5.0 | LC-FLD | 4, 6, 7, 8, 14, 15 | NR | NR | [ | |
| 0.1 M AA | Synergi 4 µ Hydro-RP 80A | 50 mM Am-acetate + 60 mM AHB, pH 5 in 1% ACN | LC-FLD | 6, 7, 14 | NR | NR | [ | |
| 0.05 M AA, CharAd † | C30- UG-5 (LC-MS/MS and LC-FLD) | 20 mM AHB + 10 mM AF in 1% ACN, pH 4 (LC-MS/MS) | LC-MS/MS | 6, 7, 8, 11, 12, 14, 15, 17, 18 | LOD: 0.7 pmol at S/N 2 | 50–1000 pmol | [ | |
| 1% AA in 70% MeOH | Develosil C30-UG-5 (HPLC-FLD and LC-MS) | 30 mM AHB in 1% ACN, pH 5 (HPLC-FLD) 20 mM AHB + 10 mM AF in 1% ACN, pH 4 (LC-MS) | HPLC-FLD | 6, 7, 8, 11, 12, 14, 17, 18 | NR | NR | [ | |
| 0.1% AA | Puresil C18 | 30 mM HFB + 1 mM Am-acetate, pH 5 | LC-MS | 6, 7, 8, 15 | NR | NR | [ |
Note: (Analyte*) Refer to Table 3 for the name of the TTX analytes.
LC-MS methods for TTX and its analogues from crab and frog.
| Species | Extraction | Column | Mobile phase | MS | Analytes * | LOD and LOQ | Linear Range | Reference |
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| 1%AA in MeOH, C18 cartridge | ODS-3 | 30 mM HFB + 1 mM Am-acetate, pH 5 | LC-MS | 6, 7, 16 | LOD: 0.005 µg/mL | 0.03–3 µg/mL | [ | |
| 1%AA in MeOH, DCM Defat *, Bio-Gel P-2 filtration | [ | [ | HPLC | 6, 16 | NR | NR | [ | |
|
| ||||||||
| MeOH:AA (96:4), Amberlite GC-50 SPE, CharAd† | CLC-ODS | 0.06N HFB + 0.001N Am-acetate, pH 5 (CLC-ODS) | LC-FLD | 4, 6, 7, 8, 9, 11, 12, 14, 17 | NR | NR | [ | |
| 1%AA in MeOH, Petroleum ether Defat*, CharAd† | CLC-ODS | 0.06N HFB + 0.001N Am-acetate, pH 5 (CLC-ODS) | LC-FLD | 4, 6, 7, 8, 9, 14 | NR | NR | [ | |
| 80% EtOH, pH 2, DCM Defat*, CharAd†, 1% AA in 20% EtOH, Bio-Gel P2 and Bio-Rex 70 filtration | Inertsil ODS-3 | 60 mM (NH4)3PO4, pH 5 + 10 mM HSA in 2% ACN | LC-FLD | 6, 8, 14, 15 | NR | NR | [ | |
Note: (Analyte*) Refer to Table 3 for the name of the TTX analytes.
LC-MS methods for TTX and its analogues from bacteria.
| Species | Extraction | Column | Mobile phase | MS | Analytes * | LOD and LOQ | Linear Range | Reference |
|---|---|---|---|---|---|---|---|---|
| 0.1% AA, CharAd †, Bio-Gel P2 and C18 SPE | ACQUITY UPLC BEH HILIC | A: 0.2% FA in H2O | Q-TOF MS | 6 | NR | 0–250 ng/mL | [ | |
| 0.1% AA, C18 SPE, CharAd † | [ | Asakawa | Asakawa | 6, 7, 16 | NR | NR | [ | |
| Vibrio strain, LM-1 from the intestine of puffer fish, | DCM Defat *, 0.03 M AA, Bio-Gel P-2 filtration | YMC-pack AM-314 octyldecyl silane | 0.05M HSA + 0.05M KH2PO4, pH 7 in MeOH | LC-FLD | 6, 7, 16 | NR | NR | [ |
| 0.1% AA, CharAd †, Bio-Gel P2 and Bio-Rex 70 filtration | Bio-Rex 70 | MeOH | LC-MS | 6 | NR | NR | [ |
Note: (Analyte*) Refer to Table 3 for the name of the TTX analytes.
LC-MS methods for TTX and its analogues from human urine and blood.
| Sample | Extraction | Column | Mobile phase | MS | Analytes * | LOD and LOQ | Linear Range | Reference |
|---|---|---|---|---|---|---|---|---|
| Postmortem whole blood | MeOH, SPE | PC(Phosphorychloline)–HILIC | 1% AA + ACN in MeOH | LC-MS/MS | 6 and voglibose | LOD: 0.32 ng/mL | 2–1200 ng/mL | [ |
| Urine and plasma | 2% AA, C18 and ZIC-HILIC SPE | Atlantics dC18 | 10 mM AF + FA (95:5, v/v) + 5 mM HFB in 2% ACN | LC-MS/MS | 6 | LOD: | 10–500 ng/mL | [ |
| Blood and urine | C18 and Oasis MCX SPE | Allsphere ODS-2 (LC-UV) | 4.8 mM 1-HSA + | LC-UV | 6 | LOD: 10 ng/mL (LC-UV) | 10–50,000 ng/mL (LC-UV) | [ |
| Cooked and raw puffer fish (liver) and human urine | 1% AA in MeOH | TosoHaas TSK-GEL Amide-80 | 5 mM AF + 26.5 mM FA in ACN: H2O, 70:30 | LC-MS/MS | 6 | 20 µg/100g tissue | 1–10,000 ng/mL | [ |
| Urine and blood | 0.5 M AA, C18 SPE | Zorax 300SB-C3 | 1% ACN + 10 mM TMA + 10 mM AF, pH 4 | LC-MS | 6 | LOD: 15.6nM | 93.75–9375 nM | [ |
| Std mixture | Not used | TSKgel Amide-80 | 16 mM AF, pH 5.5 + ACN (3:7, v/v) | LC-MS/MS | 6, 7, 14, 22 | NR | 64 pg–2 ng | [ |
| Serum | 0.5 M AA in MeOH, Oasis MCX SPE | Cosmosil HILIC 4.6 × 150 mm | 0.1% FA in water + MeOH | LC-MS/MS (M. Horie | 6, 7, 16 | LOD: 0.1 ng/mL | 1–100 ng/mL | [ |
| Urine and serum | Urine Extraction: C18 Sep-Pak SPE (0.2 M HCl in 20% MeOH) followed by Strata X-C 33 µm Cation Mixed-Mode Polymer SPE (0.1 M HCl+MeCN+MeOH+Water) | Nova-Pak C18 4 µm, 8 × 100 mm | PIC B7 (Heptane sulfonic acid), 5 mM + 3% MeCN, pH 4.5 (adjusted with conc. NH3) | LC-FLD | 6 | LOD: | 20–300 ng/mL (Urine) | [ |
Note: (Analyte*) Refer to Table 3 for the name of the TTX analytes.
Recovery of TTX from different matrices.
| Matrix | Extraction Method | % Recovery | Reference |
|---|---|---|---|
| Trumpet shell | ASE (Accelerated solvent extraction) and SE (Solvent Extraction) (0.03 M AA) (UPLC–MS/MS) | 80–92 | [ |
| Gastropod tissue | 1% AA in MeOH, C18-SPE, ultrafiltration (<3000 MW), (HPLC-FLD) | 90 | [ |
| Xanthid crab, | 1%AA in MeOH, C18-SPE, ultrafiltration (<3000 MW), (LC-MS) | 86.3 ± 2.9 | [ |
| Puffer fish ovary | 0.05M AA, ODS-SPE, ultrafiltration (0.22 µ), (LC-MS) | 94.2–9108.3 | [ |
| Puffer fish tissues, Muscle, Skin and Liver | 2% AA, methacrylate-styrene divinyl benzene cartridge (LC-MS) C18 column (50 mm × 2.1 mm i.d.) using 10 mmol/L IPCC-MS7-methanol (65:35) | Muscle 79–83 | [ |
| Puffer fish eggs and newt | 0.1% AA, Cosmosil 75C18-OPN resin-SPE, CHCl3 wash, (LC-MS) | >90 | [ |
| Newt (Whole body) | 0.1% AA in 70% MeOH, charcoal adsorption, (HPLC-FLD) | 50 | [ |
| Blood serum | 0.5 M AA and Oasis MCX-SPE, ultrafiltration (<3000 MW) (LC-MS/MS) | >95 | [ |
| Whole Blood | 1% AA in MeOH, PCX-SPE, (LC-MS/MS) | TTX 61.4Voglibose 62.8 | [ |
| Human urine and plasma | C-18 and HILIC SPE (LC-MS/MS) | 75–81 | [ |
| Human urine and blood | 0.5 M AA, C18 SPE, ultrafiltration (<3000 MW), (LC-MS) | Urine 90.9 ± 1.4 | [ |
| Human urine and blood | 2% AA, methacrylate-styrene divinyl benzene cartridge (LC-MS) C18 column (50 mm × 2.1 mm i.d.) using 10 mmol/L IPCC-MS7-methanol (65:35) | Human serum 93–96 (0.1 ng/mL) | [ |
| Combined muscle, liver and ovary from tiger puffers and muscle and ovary from balloon fishes | 1% AA in MeOH, defatted with chloroform (HPLC-FLD) | 91.0 ± 5.2 | [ |
| Puffer fish muscle, liver and phosphate buffered saline | 1% AA in MeOH, defatted with chloroform (HPLC-FLD) | 86.4 ± 18.9 | [ |
Figure 6Structure of voglibose (Internal standard for TTX).
Toxicity limits for TTX.
| Description | Value | Reference |
|---|---|---|
| Human median lethal dose | 8.7 µg/kg | [ |
| MLD for mammals (IP or IV) | 2.7–10 µg/kg for rats | [ |
| Lethal potency | 5,000–6,000 MU/mg | [ |
| MLD for human | 10,000 MU (≈2 mg) | [ |
| Regulatory limit in food in US | Zero | [ |
| LD50 of TTX in mice | 9 µg/kg | [ |
| LD99 of 5,6,11-trideoxy TTX | 750 µg/kg | [ |
| IC50 for nine human functional voltage-gated Na+ channels | ≥1 μM | [ |
| MLD of TTX to humans | 2 mg/50 kg BW | [ |
| Minimum acute dose of TTX to humans | 0.2 mg/50 kg BW | [ |
| Acceptability limit in puffer fish as food in Japan | 10 MU TTX eq/g or | [ |
| LD50 of TTX in mice, dogs and rabbits | 8–14 µg/kg by injection | [ |
| Lethal dose | 2 mg | [ |
| LD50 of TTX | 10 µg/kg (IP in mice) | [ |
| LD50 of 11-deoxy TTX | 70 µg/kg (IP in mice) | [ |
| IC50 for 6,11-dideoxy TTX | 420 µg/kg (IP in mice) | [ |
| Regulatory limit in food in Japan | 2000 µg/kg TTX eq | [ |
| Lethal doses in KM mice | LD1: 9.4 µg/kg | [ |